Ala8>ser Uses, Dosage, Side Effects and more
Ala8>ser is under investigation in clinical trial NCT03912532 (Evaluation of Efficacy, Safety and Tolerability of Ala8>ser in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)).
| Attribute | Details |
|---|---|
| Trade Name | Ala8>ser |
| Generic | Aldafermin |
| Aldafermin Other Names | (phe5>met,ser6>arg,ala8>ser,gly9>ser,his11>leu) fibroblast growth factor 19 (human fgf19) (5-194)-peptide, produced in escherichia coli, Aldafermin, Engineered variant of recombinant human fibroblast growth factor 19 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
